Improving early diagnosis of dementia in primary care
Official title: The Swedish BioFINDER - Primary Care Study
Run by Skane University Hospital · NCT06120361 · Data updated 2026-11-12
This study is trying to find better ways to diagnose Alzheimer's and other memory problems early in people visiting their primary care doctors.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 40 Years and up |
| Sex | All |
| Enrollment | 1200 (estimated) |
| Sponsor | Skane University Hospital Academic / other |
| Locations | 1 site (Malmö) |
| Status | Recruiting |
| Started | January 1, 2020 |
| Main results expected | December 31, 2028 |
| Study ends | December 31, 2028 |
| Registry record updated | April 6, 2026 |
| Trial ID | NCT06120361 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals aged 40 and older experiencing cognitive symptoms such as memory complaints or other cognitive difficulties.
✕Probably not a fit
Patients who have already been diagnosed with dementia or have cognitive impairment due to acute conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to enhance the diagnostic accuracy of Alzheimer's disease and cognitive impairment in primary care settings. It focuses on recruiting diverse patients with subjective cognitive decline, mild cognitive impairment, and mild dementia. The study will evaluate cognitive tests, blood-based biomarkers, and brain imaging methods to facilitate early diagnosis and improve patient management. By comparing traditional and novel cognitive screening tools, the study seeks to identify the most effective methods for early detection in primary care.
Why it matters
Potential benefit: If successful, this study could lead to earlier and more accurate diagnoses of dementia, improving patient care and treatment outcomes.
How similar studies have gone: Other studies have shown promise in using blood biomarkers and cognitive tests for early diagnosis of dementia, indicating a potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. The patient seeks medical help because of cognitive symptoms experienced by the patient and/or informant OR The general practitioner suspects a progressive neurodegenerative disorder including, but not limited to, Alzheimer's disease, Lewy body disease, frontotemporal lobar degeneration or subcortical vascular cognitive impairment. 2. The main symptom is usually memory complaints, but could also be executive, visuo-spatial, language, or attention complaints. 3. Age ≥40 years 4. Subjective cognitive decline, mild cognitive impairment or mild dementia Exclusion Criteria: 1. Already diagnosed dementia 2. Significant unstable systemic illness or organ failure that makes it difficult to participate. 3. Current significant alcohol or substance misuse. 4. Refusing investigation at the Memory clinic 5. Cognitive impairment with acute onset due to stroke 6. The cognitive impairment can with certainty be explained by another condition or disease such as significant anemia, infection, severe sleep deprivation, psychotic disorder, moderate-severe depression, alcohol abuse etc.
Where it's running
-
Primary care centers in Region Skåne
Malmö, Sweden Recruiting
Study contacts
- Principal investigator: Erik Stomrud, MD, PhD — Skane University Hospital and Lund University
- Study coordinator: Sebastian Palmqvist, MD, PhD
- Email: Sebastian.Palmqvist@med.lu.se
- Phone: +46-40-331000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Investigating new blood tests for diagnosing memory disorders
This study is testing new blood tests to see if they can help diagnose memory disorders like mild dementia and Alzheimer's better than the current method that uses spinal fluid.
-
Using brain stimulation and digital training to improve cognitive function in older adults
This study is testing whether a combination of brain stimulation and digital training can help improve thinking skills in older adults with Mild Cognitive Impairment and Alzheimer's Disease.
-
A study on early diagnosis and biomarkers for dementia and related diseases
This study is testing new ways to spot dementia and related diseases early by looking for specific markers in the brain and body, to help people at high risk and track how well new treatments are working.
-
Hyperspectral retinal imaging to detect Alzheimer’s and other neurodegenerative changes
This project will test whether a special retinal camera that scans many wavelengths of light can detect signs of Alzheimer’s and other neurodegenerative diseases in people with dementia or at risk.
-
Predicting disease progression in dementia using biomarkers and modeling
This study is trying to create a tool that helps predict how dementia will progress in people with mild cognitive impairment and different types of dementia, like Alzheimer's and Lewy Body Disease, by looking at brain scans, body fluids, and mental tests.
-
Effects of social isolation and interaction on dementia risk in people with subjective cognitive decline
This study is trying to see how being socially isolated or interacting with others affects the risk of dementia in people who notice early signs of memory problems.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.